Rapamycin-based inhaled therapy for potential treatment of COPD-related inflammation: production and characterization of aerosolizable nano into micro (NiM) particles

Inhalable NiM particles made from hybrid mannosylated nanostructures are able to improve the stability of loaded rapamycin, provide controlled drug release in simulated pulmonary fluid, and actively target macrophage cells.